Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include common findings: Hiatus hernia, Megacystis, Difficulty swallowing (dysphagia), and Gastroesophageal reflux and others; and sometimes findings: Megaduodenum, Ineffective esophageal peristalsis, Intestinal obstruction, and Intestinal pseudo-obstruction and others.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Digestive system | 11 | Difficulty swallowing (dysphagia), Ineffective esophageal peristalsis, Intestinal obstruction |
MYH11 encodes myosin heavy chain 11 (1,972 aa). Muscle contraction Highest expression in Esophagus Muscularis (8,418 TPM) and Colon Sigmoid (7,101 TPM).
Visceral myopathy 2 is associated with mutations in the MYH11 gene on chromosome 16.
The MYH11 protein participates in Smooth muscle/non-muscle myosin II, p-T19-MRLC-Smooth muscle/non-muscle myosin II, and p-T19,S20-MRLC-smooth muscle/non-muscle myosin II pathways.
MYH11 is classified as a druggable target (Clinically Actionable category) with score 0.0.
Genetic testing for MYH11 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for visceral myopathy 2 has been reported in the published literature.
Phenotype severity distribution: 5 common features.
No clinical trials have been registered for visceral myopathy 2.
91 publications have been identified in PubMed for visceral myopathy 2. Research spans Case Report / Case Series (36%), Review / Meta-Analysis (21%), and Epidemiology / Natural History (14%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 33 | 36% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 1:05 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Brain and nerves | 1 | Difficulty swallowing (dysphagia) |
19 |
21% |
Disease patterns and progression | 13 | 14% |
Laboratory research | 9 | 10% |
Testing and diagnosis research | 8 | 9% |
Clinical study results | 5 | 5% |
New treatment approaches | 3 | 3% |
Other research | 1 | 1% |
Mari A (2026). [PMID: 42197034](https://pubmed.ncbi.nlm.nih.gov/42197034/). *Nutrients*. [Epidemiology / Natural History]
Cocchi C (2026). [PMID: 41701472](https://pubmed.ncbi.nlm.nih.gov/41701472/). *Paediatr Drugs*. [Review / Meta-Analysis]
Salcedo Elguea EA (2026). [PMID: 41909411](https://pubmed.ncbi.nlm.nih.gov/41909411/). *Cureus*. [Case Report / Case Series]
Ikegaki S (2026). [PMID: 41699136](https://pubmed.ncbi.nlm.nih.gov/41699136/). *Mycopathologia*. [Case Report / Case Series]
Krishnasarma R (2026). [PMID: 41591435](https://pubmed.ncbi.nlm.nih.gov/41591435/). *Pediatr Radiol*. [Review / Meta-Analysis]
Takahashi K (2026). [PMID: 41952407](https://pubmed.ncbi.nlm.nih.gov/41952407/). *J Neurogastroenterol Motil*. [Epidemiology / Natural History]
Geraghty E (2026). [PMID: 41717303](https://pubmed.ncbi.nlm.nih.gov/41717303/). *J Craniovertebr Junction Spine*. [Review / Meta-Analysis]
Ezquerra-Durán A (2026). [PMID: 41812522](https://pubmed.ncbi.nlm.nih.gov/41812522/). *Med Clin (Barc)*. [Epidemiology / Natural History]
Reis AS (2026). [PMID: 41869177](https://pubmed.ncbi.nlm.nih.gov/41869177/). *Cureus*. [Case Report / Case Series]
Giri S (2026). [PMID: 41187251](https://pubmed.ncbi.nlm.nih.gov/41187251/). *Pancreas*. [Epidemiology / Natural History]